Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03464565 · ClinicalTrials.gov registry record
COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device
A clinical trial, sponsored by Penumbra.
- Completed
- Registry status
- 650
- Enrollment target
NCT03464565 is a clinical trial that has completed, run by Penumbra. The registered enrollment target is 650 participants.
The verdict
NCT03464565 has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect performance and safety data on the Penumbra System including the 3D Revascularization Device in a real world patient population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).
Interventions
- DEVICE Penumbra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2018-07-02 |
| Est. Completion | 2020-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03464565
The ClinicalTrials.gov registry entry for NCT03464565 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Penumbra System is the first listed.
NCT03464565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03464565 about?
NCT03464565 is a clinical study titled "COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device". The purpose of this registry is to collect performance and safety data on the Penumbra System including the 3D Revascularization Device in a real world patient population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).
What is the current status of trial NCT03464565?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2018-07-02. Estimated completion is 2020-01-17.
What interventions are being tested in trial NCT03464565?
The interventions under investigation include: Penumbra System (DEVICE).
Who is sponsoring clinical trial NCT03464565?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.